drug discovery

Antiverse applies machine learning to design novel antibodies against difficult targets such as GPCRs and ion channels for biomedical research.

Ainnocence provides AI-driven molecular design systems to speed up drug discovery and reduce research costs for biotech and pharmaceutical teams.

JURA.Bio combines synthetic biology and machine learning in a guided discovery platform for designing and testing next-generation cell therapies.

Menten AI applies machine learning to design novel peptide macrocycle drug candidates, aiming to reach difficult biological targets with first-principles generated data.